Nasdaq rises 1.76% to 26,434.77, gaining 456.34 points

0 min read | Published on 18 Sept 2026, 01:37 AM |Updated on 18 Sept 2026, 01:37 AM

Reviewed by

Shraddha JScanX News Team

Add as a preferred
source on Google

Key Highlights

Nasdaq closed at 26,434.77, up 456.34 points in the session
The index gained 1.76% during the session
The advance reflected a strong performance for the technology-heavy benchmark

*this image is generated using AI for illustrative purposes only.

The Nasdaq advanced 456.34 points, or 1.76%, to close at 26,434.77, posting a strong session for the technology-heavy index.

Session performance

The index recorded a notable single-session gain, with the closing level of 26,434.77 reflecting a point move of 456.34. The table below summarises the key metrics from the session.

Metric	Value
Closing level	26,434.77
Point change	+456.34
Percentage change	+1.76%

Which specific mega-cap tech stocks were the primary drivers behind the Nasdaq's 1.76% surge?

How might this rally influence investor sentiment heading into the next Federal Reserve interest rate decision?

Is the current momentum in the technology sector sustainable, or is it vulnerable to near-term profit-taking?

Nasdaq announces delisting of securities from 17 companies

1 min read | Published on 17 Sept 2026, 08:39 PM |Updated on 17 Sept 2026, 08:39 PM

Reviewed by

Ritika DScanX News Team

Add as a preferred
source on Google

Key Highlights

Nasdaq announced the delisting of securities from 17 companies on September 17, 2026
Trading suspensions for the affected companies began as early as February 23, 2026, with the most recent suspension on August 18, 2026
Affected securities include common stock, ordinary shares, Class A Common Stock, Class A Ordinary Shares, warrants, and units
Notable companies include Maxeon Solar Technologies, Sangamo Therapeutics, SPAR Group, and Keen Vision Acquisition Corporation
Nasdaq's delisting rules are governed by the Nasdaq Rule 5800 Series

*this image is generated using AI for illustrative purposes only.

Nasdaq announced on September 17, 2026 the delisting of securities from 17 companies, following trading suspensions that began as early as February 2026 and extended through August 2026.

Companies facing delisting

The affected companies span multiple sectors and share structures. Each company's securities were suspended from trading on Nasdaq prior to the delisting announcement and have not traded on the exchange since their respective suspension dates.

The following table summarises the companies, the securities being delisted, and their suspension dates:

Company	Security type	Suspension date
Abpro Holdings, Inc.	Class A Common Stock and Warrants	February 23, 2026
CIMG Inc.	Common stock	March 6, 2026
MDJM LTD	Class A Ordinary Shares	March 20, 2026
Davis Commodities Limited	Class A Ordinary Shares	March 25, 2026
Maxeon Solar Technologies, Ltd.	Ordinary shares	May 1, 2026
Sangamo Therapeutics, Inc.	Common stock	May 5, 2026
Semilux International Ltd.	Ordinary shares	June 8, 2026
Aditxt, Inc.	Common stock	June 25, 2026
Pitanium Limited	Class A Ordinary Shares	July 16, 2026
Smart Powerr Corp.	Common stock	July 21, 2026
SPAR Group, Inc.	Common stock	July 23, 2026
Nuvve Holding Corp.	Common stock	July 24, 2026
Vestand Inc.	Class A Common Stock	July 27, 2026
Empro Group Inc.	Ordinary shares	July 27, 2026
Keen Vision Acquisition Corporation	Ordinary shares, units, and warrants	August 3, 2026
Nusatrip Incorporated	Common stock	August 12, 2026
Fast Track Group	Ordinary shares	August 18, 2026

Regulatory framework

Nasdaq's rules governing the delisting of securities are set out in the Nasdaq Rule 5800 Series, available on the Nasdaq website. The exchange's delisting procedures apply uniformly to all listed securities that fail to meet continued listing standards.

Will the delisted companies attempt to relist on alternative exchanges like OTC Markets, and how might this impact their liquidity and investor access?

How might the high number of delistings in 2026 influence Nasdaq's future listing standards or enforcement policies for small-cap and distressed companies?

What are the potential tax implications for retail investors holding these suspended securities as they transition to over-the-counter trading?